Does Dr. Pikus study childhood brain cancer?

Yes, Dr. Pikus focuses on primitive neuroectodermal tumors, a type of childhood brain cancer.

What treatments has Dr. Pikus researched?

While his research primarily addresses surveillance imaging, the findings can impact treatment decisions following tumor recurrence.

Is Dr. Pikus's work relevant to improving outcomes for children with cancer?

Yes, his findings suggest that early detection of tumor recurrences through imaging can lead to better survival outcomes for these patients.

DR. HAROLD J. PIKUS, MD

LEBANON, NH

Research Active

Neurological Surgery NPI registered 21+ years 2 publications 1996 – 2019 NPI: 1801890629

Neurological Surgery

Tomography, X-Ray ComputedPostoperative ComplicationsMagnetic Resonance ImagingRisk AssessmentNeoplasm Recurrence, LocalReoperationSurvival RateNeurologic ExaminationBrain NeoplasmsCombined Modality TherapyArteriesAortic DissectionMusculoskeletal ManipulationsNeuroectodermal Tumors, Primitive

Practice Location

106 HANOVER ST
LEBANON, NH 03766-1042

Phone: (603) 448-0447

What does HAROLD PIKUS research?

Dr. Pikus studies the effectiveness of surveillance imaging in children who have undergone surgery for primitive neuroectodermal tumors, a type of brain cancer. His research focuses on how regular imaging can identify recurrences of the cancer before patients experience any symptoms. By detecting these tumors early, Dr. Pikus aims to improve the survival rates and overall health outcomes for children battling this aggressive cancer.

Key findings

In his study involving 25 children, 76% of recurrence cases were identified through routine imaging before any symptoms appeared.
Asymptomatic patients who had recurrent tumors survived more than 24 months after recurrence, compared to just 5 months for those who were symptomatic.
Regular imaging may provide critical information that allows for better treatment decisions and potentially longer survival for pediatric patients with this condition.

Frequently asked questions

Does Dr. Pikus study childhood brain cancer?: Yes, Dr. Pikus focuses on primitive neuroectodermal tumors, a type of childhood brain cancer.
What treatments has Dr. Pikus researched?: While his research primarily addresses surveillance imaging, the findings can impact treatment decisions following tumor recurrence.
Is Dr. Pikus's work relevant to improving outcomes for children with cancer?: Yes, his findings suggest that early detection of tumor recurrences through imaging can lead to better survival outcomes for these patients.

Publications in plain English

Commentary on: A risk-benefit assessment strategy to exclude cervical artery dissection in spinal manual therapy: a comprehensive review.

2019

Annals of medicine

Pikus H, Harbaugh R

PubMed

Surveillance imaging in children with primitive neuroectodermal tumors.

1996

Neurosurgery

Mendel E, Levy ML, Raffel C, McComb JG, Pikus H +2 more

Plain English
This study looked at 25 children who had surgery for primitive neuroectodermal tumors to see how effective routine imaging is for spotting cancer recurrences. Researchers found that 76% of cases with repeat tumors were detected through imaging before the kids showed any symptoms, and these asymptomatic patients lived longer—more than 24 months after recurrence—compared to those who were symptomatic, who only had an average survival of 5 months. This is important because it shows that regular imaging can help catch tumor recurrences early, potentially allowing for better treatment options. Who this helps: This helps patients with primitive neuroectodermal tumors and their doctors in making informed decisions about follow-up care.

PubMed

Frequent Co-Authors

Robert Harbaugh E Mendel M L Levy C Raffel J G McComb M D Nelson W Ganz

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.